AI-generated summary
The authors tested combined 660 nm and 808 nm low-level laser therapy against 660 nm alone in patients with oral mucositis from cancer treatment, in a single-blind controlled study. They report that the combination was associated with lower mucositis grade and fewer analgesic prescriptions, but not with a significant difference in pain scores. The authors state the effects are unclear and need more studies.
- Who or what was studied
- Patients with oral mucositis arising from oral squamous cell carcinoma treatment
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract states the effects of the combined treatment are unclear and need more studies, and does not report a sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 300 J/cm2
- Power
- 100 mW
- Total energy
- 9 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, GRADE, Wavelength, Laser, Oral mucositis, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.